The human microbiota has become one of the most fascinating areas of reproductive and neonatal medicine.
We are not biologically alone. Trillions of microorganisms inhabit the gastrointestinal tract, skin, oral cavity, and other body sites. Collectively, these microbial communities interact with metabolism, immunity, inflammation, and host physiology. During pregnancy and early infancy, the microbiome is especially interesting because this is a period of rapid biological development and microbial colonization.
The infant microbiome does not appear fully formed at birth. It develops dynamically during the first years of life and is influenced by multiple exposures, including gestational age, antibiotics, diet, breastfeeding, environmental exposures, and mode of delivery. Studies have repeatedly found differences between infants born vaginally and those born by cesarean delivery, particularly early in infancy, although the biological mechanisms and long-term clinical importance of many of these differences remain incompletely understood.1-4
That scientific uncertainty creates an important obligation: microbiome observations should not be converted into clinical claims before the evidence supports them.
And that brings us to home birth.
The microbiome argument for home birth
Supporters of planned home birth have proposed many reasons why giving birth at home might be preferable to giving birth in a hospital. Some concern autonomy, comfort, continuity of care, fewer obstetric interventions, or dissatisfaction with hospital maternity care. Those are legitimate subjects for discussion.
But another argument is biological.
Could babies born at home acquire a more favorable microbiota because they avoid the hospital environment?
It is an attractive hypothesis.
It is also, at present, unsupported.
A new 2026 report in The Lancet Microbe directly addresses this question.
Stojanov and colleagues begin by acknowledging the claim plainly:
“Supporters of home delivery suggest that neonatal microbiota associated with home birth might be healthier than that associated with hospital birth.”
The investigators had previously studied neonatal bacterial colonization in babies born at home and in hospitals. Their 2022 report found no difference in initial bacterial colonization across multiple body sites according to place of birth.
But perhaps differences emerged later.
So they went back.
What happened three years later?
The investigators reassessed 20 mother-child pairs from the original cohort. Eleven children had been born at home and nine in a hospital. Importantly, all had been delivered vaginally, which reduces the obvious confounding that would occur if one group contained substantially more cesarean deliveries.
At age 3 to 4 years, researchers sampled four sites: the armpit, forearm, stool, and saliva, using 16S rRNA gene profiling.
The result was remarkably consistent.
They found no significant difference in microbiota composition at any of the four sites between children born at home and those born in hospitals.
The beta-diversity analyses were nonsignificant for every sampled site:
armpit: p=0.18
forearm: p=0.13
stool: p=0.42
saliva: p=0.25.
There was an especially interesting additional observation.
Children born at home had been breastfed substantially longer, a median of 2.5 years compared with 0.9 years among hospital-born children. Yet even with that striking difference in feeding history, the investigators found no corresponding microbiota signature at follow-up.
By approximately age 3, the children’s microbial communities were also compositionally similar to those of their mothers at the corresponding anatomical sites. The authors concluded that anatomical location, rather than age, was driving community structure.
Their conclusion is appropriately restrained:
Differences attributable to place of birth could not be identified either during the neonatal period or at 3 to 4 years of age. They further conclude that birth setting alone should not be considered a determinant of long-term microbiota composition or assumed to protect children against allergy.
What this study does NOT prove
This is important.
The study included only 20 mother-child pairs. It used 16S rRNA profiling rather than deeper metagenomic or functional analyses. A study this small cannot demonstrate biological equivalence, exclude subtle microbial differences, or determine whether uncommon microbiome-mediated clinical outcomes differ between birth settings.
The authors appropriately call for larger longitudinal cohorts.
So we should not overstate the finding.
The correct conclusion is not:
Home and hospital birth can never affect the microbiome.
The evidence does not establish that.
The correct conclusion is:
There is currently no demonstrated microbiota advantage of home birth that should be used as a clinical argument for choosing home birth.
That distinction matters.
The larger problem: searching for biological justifications for home birth
The home-birth debate should be based on clinically important outcomes, not speculative surrogate benefits.
Planned home birth is often defended because it is associated with fewer interventions. That observation deserves serious consideration. But fewer interventions and greater maternal satisfaction cannot simply be assumed to compensate for increased neonatal risk.
In the United States, the American College of Obstetricians and Gynecologists states that planned home birth is associated with fewer maternal interventions but with a more than twofold increased risk of perinatal death and approximately threefold increased risk of neonatal seizures or serious neurologic dysfunction. ACOG therefore considers hospitals and accredited birth centers the safest birth settings, while recognizing the pregnant patient’s right to make an informed choice.5 (ACOG)
When a birth setting may increase the risk of a catastrophic neonatal outcome, even if the absolute risk is small, proponents have a responsibility to distinguish demonstrated benefits from hypothesized ones.
A “healthier microbiome” sounds compelling. It invokes nature, immunity, maternal-infant biology, and an increasingly fashionable area of science.
But biological plausibility is not evidence of clinical benefit.
Microbiome science should not become microbiome mythology
We have seen this problem before.
The microbiome is extraordinarily easy to oversell because almost any environmental exposure can be associated with differences in microbial composition. Finding a difference does not establish that the difference is beneficial. Finding an association with disease does not establish causation. And demonstrating a microbial difference does not establish that deliberately changing the exposure that produced it will improve health.
In the home-birth question, we have even less.
The investigators looked for differences and did not identify them, first in neonates and now again several years later.
That does not end microbiome research on birth environments.
It should end, at least for now, the claim that a healthier childhood microbiome is an evidence-based reason to give birth at home.
Birth setting should be judged by outcomes that matter
The appropriate comparison between home and hospital birth is not which setting feels more natural or which theoretical microbial exposure sounds more physiologic.
The relevant questions are clinical:
Does the mother survive?
Does the baby survive?
Are serious maternal complications reduced or increased?
Are neonatal seizures, hypoxic-ischemic injury, infection, and other major morbidity reduced or increased?
Can an unexpected emergency be recognized and treated quickly enough?
What maternal benefits are gained, and what neonatal risks are accepted in exchange?
Those are patient-important outcomes.
Microbiome composition is interesting science. Until it is connected convincingly to meaningful clinical outcomes, it remains primarily a biomarker and mechanistic research question, not a reason to choose a potentially less safe place of birth.
The new Lancet Microbe report does not prove that birth environment has zero effect on every component or function of the microbiome.
It tells us something more clinically useful:
After looking in the neonatal period and again 3 to 4 years later, investigators have found no evidence that home birth produces the supposedly healthier microbiota sometimes invoked in its defense.
Home birth should therefore stand or fall on its demonstrated maternal and neonatal outcomes.
The microbiome does not rescue the argument.
References
Reyman M, et al. Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. Nat Commun. 2019;10:4997.
Shao Y, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574:117-121.
Bokulich NA, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8:343ra82.
Fehr K, et al. Breastfeeding, birth mode, and other determinants of the infant gut microbiome. Microbiome. 2020;8:131.
American College of Obstetricians and Gynecologists. Planned Home Birth. Committee Opinion No. 697. Obstet Gynecol. 2017;129:e117-e122.
Hutton EK, Reitsma A, Simioni J, Brunton G, Kaufman K. Perinatal or neonatal mortality among women who intend at the onset of labour to give birth at home compared with women of low obstetrical risk who intend to give birth in hospital: a systematic review and meta-analyses. EClinicalMedicine. 2019;14:59-70.
Stojanov M, Savoy F, Baud D. Home or hospital birth: a 3-year microbiota follow-up. Lancet Microbe. 2026. doi:10.1016/j.lanmic.2026.101526.